Peripheral blood transcriptomic analysis identifies potential inflammation and immune signatures for central retinal artery occlusion

Jiaqing Feng,Ying Li,Chuansen Wang,Yuedan Wang,Yuwei Wan,Mengxue Zheng,Ting Chen,Xuan Xiao
DOI: https://doi.org/10.1038/s41598-024-57052-8
IF: 4.6
2024-03-30
Scientific Reports
Abstract:Central retinal artery occlusion (CRAO) is an acute retinal ischaemic disease, but early diagnosis is challenging due to a lack of biomarkers. Blood samples were collected from CRAO patients and cataract patients. Gene expression profiles were distinct between arterial/venous CRAO blood (A–V group) and venous CRAO/control blood (V–C group) samples. Differentially expressed genes (DEGs) were subjected to GO and KEGG enrichment analyses. Hub genes were identified by Cytoscape and used to predict gene interactions via GeneMANIA. Immune cell infiltration was analysed by CIBERSORT. More than 1400 DEGs were identified in the A–V group and 112 DEGs in the V–C group compared to controls. The DEGs in both groups were enriched in the ribosome pathway, and those in the V–C group were also enriched in antigen processing/MHC pathways. Network analysis identified ribosomal proteins ( RPS2 and RPS5 ) as the core genes of the A–V group and MHC genes ( HLA-F ) as the core genes of the V–C group. Coexpression networks showed ribosomal involvement in both groups, with additional immune responses in the V–C group. Immune cell analysis indicated increased numbers of neutrophils and T cells. Ribosomal and MHC-related genes were identified as potential CRAO biomarkers, providing research directions for prevention, diagnosis, treatment and prognosis.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the early diagnosis of central retinal artery occlusion (CRAO) and the identification of potential biomarkers. CRAO is an acute retinal ischemic disease, and its early diagnosis is challenging due to the lack of effective biomarkers. By analyzing the peripheral blood transcriptome of CRAO patients, this paper aims to discover potential biomarkers related to inflammation and immune responses, in order to provide new research directions for the prevention, diagnosis, treatment, and prognosis of CRAO. Specifically, the paper solves the problem through the following steps: 1. **Sample collection**: Blood samples are collected from CRAO patients and cataract control groups. 2. **Gene expression profile analysis**: RNA sequencing technology is used to analyze the gene expression profiles of different groups (arterial/venous CRAO blood sample group [A - V group] and venous CRAO/control blood sample group [V - C group]). 3. **Differentially expressed genes (DEGs) identification**: Differentially expressed genes between the two groups are identified by bioinformatics methods. 4. **Functional enrichment analysis**: GO and KEGG enrichment analysis are performed on the differentially expressed genes to determine the functions of these genes in biological processes. 5. **Core gene and protein - protein interaction network analysis**: Cytoscape is used to construct a protein - protein interaction network, and core genes are screened out by multiple algorithms. 6. **Immune cell infiltration analysis**: The CIBERSORT algorithm is used to analyze the proportion changes of immune cells in peripheral blood. Through the above steps, the paper discovers: - There are more than 1,400 differentially expressed genes in the A - V group and 112 differentially expressed genes in the V - C group. - These differentially expressed genes are mainly enriched in the ribosomal pathway, and the V - C group is also enriched in the antigen processing/MHC pathway. - Core genes include ribosomal proteins (such as RPS2 and RPS5) and MHC genes (such as HLA - F). - Immune cell analysis shows that the numbers of neutrophils and T cells increase. These findings provide new insights into the pathological mechanism of CRAO and lay the foundation for the development of more effective treatment methods.